Product Information
CLOBAZAM 2.5 MG/ML SUSPENSION is a generic product labeled by Bionpharma Inc., priced at $0.1687 per ML under NDC 69452011645. Its NADAC has been published 396 times since Jan 23, 2019.
FDA first approved this application on Oct 22, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/mL
Manufacturer
Bionpharma Inc.NDC
69452011645
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA208819FDA Approved
10/22/2018
TE Code
AB
On Market Since
10/20/2017
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has been published 396 times since Jan 23, 2019, and over the history we have for it it has declined 87.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1687 per ML |
|---|---|
| All-time high | $1.4486 (Mar 13, 2019) |
| All-time low | $0.1530 (May 20, 2026) |
| 52-week high | $0.1928 |
| 52-week low | $0.1530 |
| Median price | $0.3747 |
| Average price | $0.4395 |
| Largest weekly change | -41.1% (Sep 23, 2020) |
| Weeks tracked | 396 |
| Tracking since | Jan 23, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOBAZAM 2.5 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 2.5 MG/ML SUSPENSION, manufactured by Bionpharma Inc., is $0.1687 per ML (NDC 69452011645), effective Aug 19, 2026.
How has the price of CLOBAZAM 2.5 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has declined 87.4%. It has been tracked across 396 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 2.5 MG/ML SUSPENSION?
Since Jan 23, 2019, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has ranged from a low of $0.1530 (May 20, 2026) to a high of $1.4486 (Mar 13, 2019), with a median of $0.3747 per ML.
Are there cheaper alternatives to CLOBAZAM 2.5 MG/ML SUSPENSION?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOBAZAM 2.5 MG/ML SUSPENSION in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOBAZAM 2.5 MG/ML SUSPENSION?
CLOBAZAM 2.5 MG/ML SUSPENSION (NDC 69452011645) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.